Comstock Holding reports Q4 EPS 99c vs. 18c last year
Q4 Revenue Growth: Comstock reported a Q4 revenue of $16.91 million, an increase from $11.02 million the previous year, highlighting a consistent growth trend over seven years with a compound annual growth rate (CAGR) of 25%.
Future Investment Plans: The company aims to leverage its strong cash flow and streamlined balance sheet for further investments in 2025 and beyond, reinforcing its position as a leading real estate service provider in the Washington, D.C. area.
Trade with 70% Backtested Accuracy
Analyst Views on CHCI
About CHCI
About the author
Three Small-Cap Stocks to Watch in 2026
Podcast Overview: Episode #467 of the Zacks Market Edge Podcast features host Tracey Ryniec and guest Mark Zinski discussing three small-cap stocks in real estate and banking to consider for 2026, moving away from AI-focused investments.
Comstock Holding Companies (CHCI): This asset manager and developer in the Washington DC area has seen a 64% increase in shares year-to-date, with a market cap of $135 million and a price-to-book ratio of 2.4, but does not pay dividends.
C&F Financial Corp. (CFFI): A Virginia-based bank with a market cap of $224 million, C&F Financial has a dividend yield of 2.7% and is attractively priced with a P/B ratio of 0.9, despite a 3.4% decline in shares year-to-date.
Bank of the James Financial Group (BOTJ): This Central Virginia bank has a market cap of $80 million, pays a dividend yielding 2.2%, and has seen a 12.2% increase in shares year-to-date, trading at a P/B ratio of 1.2.
Zacks Analyst Blog Features Visa, Merck, Southern Company, Community Bancorp, and Comstock
Featured Stocks: The Zacks Analyst Blog highlights stocks including Visa Inc., Merck & Co., The Southern Co., Community Bancorp, and Comstock Holding Companies, with a focus on their recent performance and market outlook.
Visa Inc. Overview: Visa's shares have outperformed its industry, driven by strong earnings, growth in cross-border transactions, and investments in technology, although it faces challenges from rising expenses and regulatory pressures.
Merck & Co. Insights: Merck has underperformed its industry due to competitive pressures and challenges with its key drug, Keytruda, but has seen growth from new products and is pursuing M&A to enhance its pipeline.
Southern Company and Microcap Stocks: Southern Company shows stable growth potential despite high leverage risks, while Community Bancorp and Comstock Holding Companies have outperformed their respective industries, supported by strong earnings and strategic growth initiatives.
